CONFORM Pivotal Trial Site Recruitment Meeting

Published: 16 June 2021

  • Views:

    Views Icon 1271

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

The CONFORM Pivotal Trial is a prospective, multi-center randomized controlled trial, designed to evaluate the safety and effectiveness of the Conformal Left Atrial Appendage Seal (CLAAS®). Subjects will be randomized in a 1:1 fashion between the CLAAS device (treatment) or a Boston Scientific LAA closure device (Control).

 

If interested in participating in the Conform Pivotal Study, please contact Karis Oasan, Clinical Trial Manager koasan@conformalmedical.com.

 

For more information on Conformal Medical, Inc click HERE to visit our website.

This session is a clinical trial recruitment event.

Target Audience

  • Interventional Cardiologists
  • Electrophysiologists
  • All sites specialising in LAA procedures or doing research in this space

More from this programme

Part 1

Welcome and Introductions

Presented by Andy Levine
1 session
Welcome and Introductions Watch now

Part 2

CLAAS Overview

Presented by Dr Aaron Kaplan
1 session
CLAAS Overview Watch now

Part 3

Initial Clinical Experience

Presented by Dr Aaron Kaplan
1 session
Initial Clinical Experience Watch now

Part 4

Case Study and Panel Discussion 1

Presented by Dr William Gray with discussion moderated by Dr Aaron Kaplan and Dr Shephal Doshi
1 session
Case Study and Panel Discussion 1 Watch now

Part 5

Case Study and Panel Discussion 2

Presented by Dr Vivek Reddy with discussion moderated by Dr Aaron Kaplan and Dr Shephal Doshi
1 session
Case Study and Panel Discussion 2 Watch now

Part 6

CONFORM Pivotal Trial Summary

Presented by Chris Cain
1 session
CONFORM Pivotal Trial Summary Watch now

Part 7

Closing Remarks

Presented by Dr Aaron Kaplan
1 session
Closing Remarks Watch now

Faculty Biographies

William Gray

William Gray

President of the Lankenau Heart Institute

Dr William Gray is an interventional cardiologist, board certified in internal medicine, cardiology, interventional cardiology, vascular medicine and endovascular medicine.  He was at the Center for Interventional Vascular Therapy (CIVT) as Director, Endovascular Intervention at New York Columbia-Presbyterian Hospital from 2005-2015 before joining the Main Line Health System in Wynnewood, Pennsylvania.   He specializes in cardiac/structural and peripheral arterial disease diagnosis and treatment with a special interest in new, non-surgical modalities for stroke prevention (carotid stenting and left atrial appendage occlusion devices), and research into preventing the reoccurrence of disease following successful angioplasty or stenting.  He has also dedicated a significant portion of the past decade of his career to the non-surgical management of mitral regurgitation.…

View full profile